BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34906980)

  • 1. Association of Cognitive Impairment With Free Water in the Nucleus Basalis of Meynert and Locus Coeruleus to Transentorhinal Cortex Tract.
    Chu WT; Wang WE; Zaborszky L; Golde TE; DeKosky S; Duara R; Loewenstein DA; Adjouadi M; Coombes SA; Vaillancourt DE
    Neurology; 2022 Feb; 98(7):e700-e710. PubMed ID: 34906980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
    Schumacher J; Ray NJ; Hamilton CA; Donaghy PC; Firbank M; Roberts G; Allan L; Durcan R; Barnett N; O'Brien JT; Taylor JP; Thomas AJ
    Brain; 2022 Jun; 145(5):1773-1784. PubMed ID: 34605858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined in vivo MRI assessment of locus coeruleus and nucleus basalis of Meynert integrity in amnestic Alzheimer's disease, suspected-LATE and frontotemporal dementia.
    Lagarde J; Olivieri P; Tonietto M; Noiray C; Lehericy S; Valabrègue R; Caillé F; Gervais P; Moussion M; Bottlaender M; Sarazin M
    Alzheimers Res Ther; 2024 May; 16(1):97. PubMed ID: 38702802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?
    Jethwa KD; Dhillon P; Meng D; Auer DP;
    AJNR Am J Neuroradiol; 2019 Dec; 40(12):2039-2044. PubMed ID: 31727757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrity of the nucleus basalis of meynert and self-reported cognitive dysfunction during wearing-off periods in parkinson's disease.
    Lench DH; Turner TH; Wetmore E; Rodriguez-Porcel FJ; Revuelta GJ
    Brain Imaging Behav; 2024 Feb; 18(1):256-261. PubMed ID: 37889445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer's disease - Evidence from an MRI-based meta-analysis.
    Mieling M; Meier H; Bunzeck N
    Neurosci Biobehav Rev; 2023 Nov; 154():105393. PubMed ID: 37717861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.
    Schulz J; Pagano G; Fernández Bonfante JA; Wilson H; Politis M
    Brain; 2018 May; 141(5):1501-1516. PubMed ID: 29701787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
    Shafiee N; Fonov V; Dadar M; Spreng RN; Collins DL
    Neurobiol Aging; 2024 Jul; 139():54-63. PubMed ID: 38608458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment.
    Cantero JL; Zaborszky L; Atienza M
    Cereb Cortex; 2017 Aug; 27(8):3881-3889. PubMed ID: 27371762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease.
    Guttuso T; Sirica D; Tosun D; Zivadinov R; Pasternak O; Weintraub D; Baglio F; Bergsland N
    Mov Disord; 2022 Mar; 37(3):490-501. PubMed ID: 34936139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Functional Connectivity of the Basal Nucleus of Meynert in Subjective Cognitive Impairment, Early Mild Cognitive Impairment, and Late Mild Cognitive Impairment.
    Xu W; Rao J; Song Y; Chen S; Xue C; Hu G; Lin X; Chen J
    Front Aging Neurosci; 2021; 13():671351. PubMed ID: 34248603
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies.
    Schumacher J; Taylor JP; Hamilton CA; Firbank M; Cromarty RA; Donaghy PC; Roberts G; Allan L; Lloyd J; Durcan R; Barnett N; O'Brien JT; Thomas AJ
    Neuroimage Clin; 2021; 30():102604. PubMed ID: 33711623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural (dys)connectivity associates with cholinergic cell density in Alzheimer's disease.
    Lin CP; Frigerio I; Boon BDC; Zhou Z; Rozemuller AJM; Bouwman FH; Schoonheim MM; van de Berg WDJ; Jonkman LE
    Brain; 2022 Aug; 145(8):2869-2881. PubMed ID: 35259207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daytime sleepiness in dementia with Lewy bodies is associated with neuronal depletion of the nucleus basalis of Meynert.
    Kasanuki K; Ferman TJ; Murray ME; Heckman MG; Pedraza O; Hanna Al-Shaikh FS; Mishima T; Diehl NN; van Gerpen JA; Uitti RJ; Wszolek ZK; Graff-Radford NR; Dickson DW
    Parkinsonism Relat Disord; 2018 May; 50():99-103. PubMed ID: 29429645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct glutaminyl cyclase expression in Edinger-Westphal nucleus, locus coeruleus and nucleus basalis Meynert contributes to pGlu-Abeta pathology in Alzheimer's disease.
    Morawski M; Hartlage-Rübsamen M; Jäger C; Waniek A; Schilling S; Schwab C; McGeer PL; Arendt T; Demuth HU; Rossner S
    Acta Neuropathol; 2010 Aug; 120(2):195-207. PubMed ID: 20383514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial Pattern Separation in Early Alzheimer's Disease.
    Parizkova M; Lerch O; Andel R; Kalinova J; Markova H; Vyhnalek M; Hort J; Laczó J
    J Alzheimers Dis; 2020; 76(1):121-138. PubMed ID: 32444544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia.
    Hardenacke K; Kuhn J; Lenartz D; Maarouf M; Mai JK; Bartsch C; Freund HJ; Sturm V
    World Neurosurg; 2013; 80(3-4):S27.e35-43. PubMed ID: 23246738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
    Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
    Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    Richter N; David LS; Grothe MJ; Teipel S; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Onur OA; Kukolja J
    J Alzheimers Dis; 2022; 86(1):425-440. PubMed ID: 35068451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.